GlassScriptPrepare for your visit
Michelle D Schreck
Pediatrics (Nurse Practitioner) · St. Petersburg, FL · NPI 1548445018
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$650.59
in general payments reported to CMS, 2019-2025 · $315 in 2025
The $315 reported for 2025 was more than what 86% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
Who reported paying
General payments only, top 6 by amount.
- Neuraxis, INC. $162.20
- Galderma Laboratories, L.P. $130.65
- Regeneron Healthcare Solutions, INC. $121.46
- Qol Medical, LLC $85.02
- Takeda Pharmaceuticals U.S.A., INC. $77.98
- Pharming Healthcare, INC. $24.68
Drugs and devices associated with these payments
Nemluvio Dupixent Sucraid Ruconest Gattex Bylvay Zenpep
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Michelle Schreck listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10643070/michelle-d-schreck